FLT3 internal tandem duplication (FLT3/ITD) occurs in approximately 10% to 20% of pediatric AML cases and conveys a poor prognosis, which is favorably modified by the presence of a low allelic ratio or concomitant NPM1 mutations. This evidence concerns the gene FLT3 and acute myeloid leukemia.